These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35248606)

  • 21. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
    Sakashita M; Mochizuki S; Sakurai K
    Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
    Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAMAM-pullulan conjugates as targeted gene carriers for liver cell.
    Askarian S; Abnous K; Ayatollahi S; Farzad SA; Oskuee RK; Ramezani M
    Carbohydr Polym; 2017 Feb; 157():929-937. PubMed ID: 27988010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Well-Defined Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor.
    Huang X; Leroux JC; Castagner B
    Bioconjug Chem; 2017 Feb; 28(2):283-295. PubMed ID: 27966887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell Type-Specific Delivery of RNAi by Ligand-Functionalized Curdlan Nanoparticles: Balancing the Receptor Mediation and the Charge Motivation.
    Wu Y; Cai J; Han J; Baigude H
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21521-8. PubMed ID: 26345600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo.
    Rensen PC; Sliedregt LA; Ferns M; Kieviet E; van Rossenberg SM; van Leeuwen SH; van Berkel TJ; Biessen EA
    J Biol Chem; 2001 Oct; 276(40):37577-84. PubMed ID: 11479285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galactosylated alginate-curcumin micelles for enhanced delivery of curcumin to hepatocytes.
    Sarika PR; James NR; Kumar PR; Raj DK
    Int J Biol Macromol; 2016 May; 86():1-9. PubMed ID: 26774374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Zhang B; Zhang Y; Yu D
    Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Novel Small-Molecule ASGP-R Ligands.
    Majouga AG; Ivanenkov YA; Veselov MS; Lopuhov AV; Maklakova SV; Beloglazkina EK; Binevski PV; Klyachko NL; Sandulenko YB; Galkina NY; Koteliansky VE
    Curr Drug Deliv; 2016; 13(8):1303-1312. PubMed ID: 27440073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development.
    Li Y; Huang G; Diakur J; Wiebe LI
    Curr Drug Deliv; 2008 Oct; 5(4):299-302. PubMed ID: 18855599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lectin recognition and hepatocyte endocytosis of GalNAc-decorated nanostructured lipid carriers.
    Gauthier L; Chevallet M; Bulteau F; Thépaut M; Delangle P; Fieschi F; Vivès C; Texier I; Deniaud A; Gateau C
    J Drug Target; 2021 Jan; 29(1):99-107. PubMed ID: 32936032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy.
    Zheng G; Zhao R; Xu A; Shen Z; Chen X; Shao J
    Eur J Pharm Sci; 2018 Jan; 111():492-502. PubMed ID: 29107835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor.
    Sanhueza CA; Baksh MM; Thuma B; Roy MD; Dutta S; Préville C; Chrunyk BA; Beaumont K; Dullea R; Ammirati M; Liu S; Gebhard D; Finley JE; Salatto CT; King-Ahmad A; Stock I; Atkinson K; Reidich B; Lin W; Kumar R; Tu M; Menhaji-Klotz E; Price DA; Liras S; Finn MG; Mascitti V
    J Am Chem Soc; 2017 Mar; 139(9):3528-3536. PubMed ID: 28230359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.
    Zhao R; Zheng G; Fan L; Shen Z; Jiang K; Guo Y; Shao JW
    Acta Biomater; 2018 Apr; 70():197-210. PubMed ID: 29408311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery.
    Li YL; Zhu XM; Liang H; Orvig C; Chen ZF
    Curr Med Chem; 2021; 28(8):1508-1534. PubMed ID: 32368967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of Surface GalNAc Ligands Decorating Nanostructured Lipid Carriers by UPLC-ELSD.
    Gauthier L; Varache M; Couffin AC; Lebrun C; Delangle P; Gateau C; Texier I
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superparamagnetic iron oxide nanoparticles as a dual imaging probe for targeting hepatocytes in vivo.
    Lee CM; Jeong HJ; Kim EM; Kim DW; Lim ST; Kim HT; Park IK; Jeong YY; Kim JW; Sohn MH
    Magn Reson Med; 2009 Dec; 62(6):1440-6. PubMed ID: 19859969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional evaluation of poly-(N-p-vinylbenzyl-O-beta-D-galactopyranosyl-[1-4]-D-gluconamide)(PVLA) as a liver specific carrier.
    Watanabe Y; Liu X; Shibuya I; Akaike T
    J Biomater Sci Polym Ed; 2000; 11(8):833-48. PubMed ID: 11211095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core-shell nanoparticles based on pullulan and poly(β-amino) ester for hepatoma-targeted codelivery of gene and chemotherapy agent.
    Liu Y; Wang Y; Zhang C; Zhou P; Liu Y; An T; Sun D; Zhang N; Wang Y
    ACS Appl Mater Interfaces; 2014; 6(21):18712-20. PubMed ID: 25289563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of DNA using YEE(GalNAcAH)3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor.
    Merwin JR; Noell GS; Thomas WL; Chiou HC; DeRome ME; McKee TD; Spitalny GL; Findeis MA
    Bioconjug Chem; 1994; 5(6):612-20. PubMed ID: 7873664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.